Take That, Death
Summary
Host Ben Bradford explores the scientific quest to reverse aging, featuring reporter Susan Dominis. They discuss the discovery of Yamanaka factors, which allow cells to be reprogrammed to a younger state, and the race by secretive, billionaire-funded labs like Altos Labs to develop these treatments. The episode covers the transition from animal models to human clinical trials, highlighting the potential to extend healthy lifespan and the ethical concerns regarding access and safety.
Topics discussed
Sponsor and show schedule update
Introduction: The myth of eternal life
The scientific quest to reverse aging
Why animals age at different rates
Cynthia Kenyon's roundworm gene discovery
The cement analogy and mesenchymal drift
Evolutionary perspective on aging
Why babies are born young: The cellular reset
Shinya Yamanaka and the discovery of stem cell factors
Sponsor breaks and NPR podcast promos
The mouse experiment and teratoma risks
Partial rejuvenation in mice
Billionaire funding and Altos Labs
Inside Altos Labs: Organoids and human cells
Ethical concerns and power dynamics
Summary and the question of doom
Current human trials for glaucoma
Optimistic vs dystopian futures
Healthspan vs lifespan and FDA regulations
Next episode preview and credits
Listen ad-free on Castria